Ronald Blue Trust, Inc. Laboratory Corp Of America Holdings Transaction History

Ronald Blue Trust, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$192.5 - $216.35 $317,047 - $356,328	1,647 Added 1128.08%	1,793 $364,000
Q1 2024 May 01, 2024	BUY	$209.01 - $232.56 $5,016 - $5,581	24 Added 19.67%	146 $31,000
Q4 2023 Jan 18, 2024	SELL	$197.69 - $227.29 $4,744 - $5,454	-24 Reduced 16.44%	122 $24,000
Q3 2023 Oct 11, 2023	BUY	$201.05 - $221.7 $7,639 - $8,424	38 Added 35.19%	146 $35,000
Q2 2023 Jul 14, 2023	SELL	$211.93 - $241.33 $52,346 - $59,608	-247 Reduced 69.58%	108 $24,000
Q1 2023 Apr 17, 2023	SELL	$213.32 - $257.83 $25,171 - $30,423	-118 Reduced 24.95%	355 $84,000
Q4 2022 Jan 17, 2023	BUY	$203.72 - $248.97 $47,466 - $58,010	233 Added 97.08%	473 $96,000
Q3 2022 Oct 21, 2022	BUY	$204.81 - $262.19 $15,975 - $20,450	78 Added 48.15%	240 $56,000
Q2 2022 Aug 09, 2022	BUY	$213.86 - $277.87 $34,645 - $45,014	162 New	162 $42,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.